Skip to main content

AsclepiX Therapeutics

Baltimore, United States

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.

$10.0M raised
Jul 2023
Series A

Top Investors

TEDCOPerceptive AdvisorsSalem PartnersRapha Capital ManagementPiedmont Capital Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about AsclepiX Therapeutics

How much funding has AsclepiX Therapeutics raised?
AsclepiX Therapeutics has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in July 2023.
Who are AsclepiX Therapeutics's investors?
AsclepiX Therapeutics's investors include TEDCO, Perceptive Advisors, Salem Partners, Rapha Capital Management, Piedmont Capital Partners.
Where is AsclepiX Therapeutics headquartered?
AsclepiX Therapeutics is headquartered in Baltimore, United States.
What does AsclepiX Therapeutics do?
AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.
What stage is AsclepiX Therapeutics at?
AsclepiX Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"AsclepiX Therapeutics — Funding & Investors." VCBacked, July 26, 2023, https://www.vcbacked.co/company/asclepix-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2023). AsclepiX Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/asclepix-therapeutics
Wikipedia (cite web)
{{cite web |title=AsclepiX Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/asclepix-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .